- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/62 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
Patent holdings for IPC class G01N 33/62
Total number of patents in this class: 89
10-year publication summary
8
|
14
|
12
|
5
|
7
|
7
|
5
|
8
|
2
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Labrador Diagnostics LLC | 287 |
9 |
Roche Diagnostics Operations, Inc. | 1375 |
3 |
Church & Dwight Co., Inc. | 1845 |
3 |
Arizona Board of Regents on behalf of Arizona State University | 2226 |
3 |
The Regents of the University of California | 18943 |
2 |
Ajinomoto Co., Inc. | 2337 |
2 |
Agency for Science, Technology and Research | 3512 |
2 |
Duke University | 2872 |
2 |
Aurinia Pharmaceuticals Inc. | 80 |
2 |
Dignity Health | 450 |
2 |
Instrumentation Laboratory Company | 227 |
2 |
Metanomics GmbH | 26 |
2 |
Radiometer Medical ApS | 164 |
2 |
Sierra Molecular Corporation | 5 |
2 |
Spectrum Laboratories, LLC | 8 |
2 |
Okayama Prefecture Industrial Promotion Foundation | 6 |
2 |
Infagen (Hong Kong) Limited | 2 |
2 |
The Procter & Gamble Company | 22178 |
1 |
Samsung Electronics Co., Ltd. | 131630 |
1 |
F. Hoffmann-La Roche AG | 7958 |
1 |
Other owners | 42 |